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Abstract
Some environmental contaminants interact with hormones and may exert adverse consequences
due to their actions as endocrine disrupting chemicals (EDCs). Exposure in people is typically due
to contamination of the food chain, inhalation of contaminated house dust, or occupational
exposure. EDCs include pesticides and herbicides (such as diphenyl-dichloro-trichloroethane,
DDT, or its metabolites), methoxychlor, biocides, heat stabilizers and chemical catalysts (such as
tributyltin, TBT), plastic contaminants (e.g. bisphenol A, BPA), pharmaceuticals (i.e.
diethylstilbestrol, DES; 17alpha-ethynilestradiol, EE2), or dietary components (such as
phytoestrogens). The goal of this review is to address sources, effects and actions of EDCs, with
an emphasis on topics discussed at the International Congress on Steroids and the Nervous
System. EDCs may alter reproductively-relevant or non-reproductive, sexually-dimorphic
behaviors. In addition, EDCs may have significant effects on neurodevelopmental processes,
influencing morphology of sexually-dimorphic cerebral circuits. Exposure to EDCs is more
dangerous if it occurs during specific “critical periods” of life, such as intrauterine, perinatal,
juvenile or puberty periods, when organisms are more sensitive to hormonal disruption, than in
other periods. However, exposure to EDCs in adulthood also can alter physiology. Several EDCs
are xenoestrogens, may alter serum lipid concentrations, or metabolism enzymes that are
necessary for converting cholesterol to steroid hormones, ultimately altering production of E2 and/
or other steroids. Finally, many EDCs may have actions via, or independent of, classic actions at
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cognate steroid receptors. EDCs may have effects through numerous other substrates, such as the
aryl hydrocarbon receptor (AhR), the peroxisome proliferator-activated receptor (PPAR) and
retinoid X receptor (RXR), signal transduction pathways, calcium influx, and/or neurotransmitter
receptors. Thus, EDCs, from varied sources, may have organizational effects during development,
and/or activational effects in adulthood, that influence sexually-dimorphic, reproductively-relevant
processes or other functions, by mimicking, antagonizing, or altering steroidal actions.
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xenoestrogens; diphenyl-dichloro-trichloroethane; methoxychlor; biocides; tributyltin; bisphenol
A; diethylstilbestrol; ethynilestradiol; phytoestrogens; aryl hydrocarbon receptor; the peroxisome
proliferator-activated receptor; retinoid X receptor
Introduction
Endogenous steroid hormones, during critical periods of development, organize sexual
dimorphisms in brain and behavior and give rise to sex differences in later responses to
steroid hormones (1, 2). These mechanisms have evolved over time to ensure the survival of
species and maximize the fitness of each sex. This delicate balance may be at risk, in part
because a growing number of contaminants in the environment can accumulate in exposed
individuals and may have adverse consequences due to their action as endocrine disrupting
chemicals (EDCs). Thousands of chemicals, some banned and some still in use, have been
classified as EDCs. They produce their effects by mimicking, antagonizing, or altering
endogenous steroid levels (androgens or estradiol, E2) via changing rates of their synthesis
or metabolism and/or expression or action at receptor targets.
The goal of this review is to address some of the sources, effects and mechanisms of EDCs.
The breadth of this topic precludes comprehensive coverage of all EDCs. As such, this
review focuses on topics that have been part of the ongoing dialogue at The International
Congress of Steroids and The Nervous System. First, the sources of common
neuroendocrine disrupting compounds will be described. Second, the effects of EDCs to
alter reproductively-relevant, sexually-dimorphic behaviors, and whether there are sex
differences in the effects of EDCs, will be examined. Third, the role of EDCs for sexually-
dimorphic, non-reproductive behaviors, and in sex-linked developmental disorders
(neurodevelopmental, neuropsychiatric, neurodegenerative), is discussed. Fourth, the extent
to which these effects of EDCs are differentially programmed (or expressed), based upon
critical developmental periods is addressed. Fifth, the species differences in EDCs’ effects,
and the ecological systems issues (e.g. food chain), is considered. Sixth, the actions of EDCs
via altering steroid metabolism, steroid receptor action, and non-traditional receptor targets,
as well as altering gonadal steroid dependent neural circuits is discussed. Thus, this review
summarizes some of the evidence that EDCs (such as those in Table 1) can profoundly alter
reproductive responses following adult exposure and that EDC exposure can result in
pervasive effects that extend throughout the life of their progeny (3, 4).
Sources of Contaminants
There are varied sources of environmental contaminants. Typical human exposure occurs
with environmental contamination of the food chain, especially fresh water fish and meat,
contact with contaminated household dust, and occupational (5-10). Some were banned or
otherwise removed from production years ago, but persist in the environment. For example,
a family of industrial PCB compounds, often sold as mixtures (Aroclor), generally act as
estrogen mimics and are still found in significant quantities in the environment, although
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their manufacture in the U.S. was banned in 1977. In certain uses, PCBs can partially
oxidize and themselves become contaminated by extremely toxic compounds, such as
polychlorinated dibenzofurans (PCDFs). In some areas, PCB levels in drinking water ranged
from 100 to 450 ng/l; in food products, levels were over 200 mg/kg fresh weight. PCB levels
in occupationally-exposed workers ranged from 2.2 to 290 ppm in adipose tissue and blood
concentrations in capacitor manufacturing workers were up to 3.5 μg/ml (11).
Other EDCs are high production volume chemicals found in a myriad of household
products. Bisphenol A (BPA), for example, is present in polycarbonate plastics, including
beverage and food storage containers, epoxy resins that line the interior of metal cans, and in
the ink used for thermal paper receipts. Many textiles contain contaminants, such as flame-
retardants, including tetrabromobisphenol A (TBBPA) and polybrominated diphenyl ethers
(PBDE). Some individuals have also been exposed to contaminants with adverse effects due
to medical (diethylstilbestrol; DES), dental (diglycidyl methacrylate), or dietary
(phytoestrogens) interventions. Synthetic estrogens from anticonceptional pills, such as
ethynilestradiol (EE2), are commonly found in surface water, because of their widespread
use (12). Thus, exposure to EDCs is ubiquitous and unavoidable and there is growing
concern that living in an EDC contaminated world may be contributing to adverse health
trends, such as early puberty and infertility, because of growing evidence that a number of
EDCs can produce varied effects (13), described below.
Effects of EDCs to alter reproductively-relevant, sexually-dimorphic
neuroendocrine systems and behaviors
Exposure to EDCs has been associated with a myriad of adverse reproductive outcomes
including reduced female fecundity, longer time to conception, higher miscarriage rates, and
decreased sperm motility (14-15). Studies examining the effects of EDCs on sexual
maturation offer further evidence for a possible connection between EDCs and reproduction
(16-17). Emerging evidence supports the long held suspicion that age at menarche is
advancing in girls, particularly in developed countries (18-19). This observation has led to
the hypothesis that exposure to EDCs could be a contributing factor (20-21). Exposure to
EDCs has been associated with earlier age at menarche and sexual development in breast-
fed girls (22), although some studies have shown the opposite effect, with girls exposed to
EDCs showing delayed sexual maturation (23). This type of nonlinear response, where
effects differ at low and high dosages may be typical for EDCs (24) and is a phenomenon
that has raised concern over low dose exposure (25-26). Mixtures can also influence effects.
For example, a report on exposure to EDCs and lead shows that it may advance and delay,
respectively, age of menarche, indicating that EDC exposure in combination with lead and
other toxicants needs to be considered when attempting to understand how exposure may
influence reproductive health (22).
Adverse effects of EDC exposure on reproductive physiology have also been seen in
numerous animal models, particularly when exposure occurs early in development (27-28).
In mammal and other vertebrates, EDC exposure during development alters both male and
female gonad development, reduction in sperm counts, abnormal sperm, and changes in
sexual behavior, such as demasculinization and feminization of male offspring (for reviews
see 29-31). Lactational exposure of rats to Aroclor 1254 (8, 32, or 64 mg/kg to dams)
decreased mating behavior, reproductive success, and ventral prostate and testicular weights
of male pups in adulthood (32). Females exposed had delayed puberty, decreased uterine
weight, impaired fertility, and irregular estrous cycles (33). As well, acute exposure to
Aroclor 1254 (from neonatal day 1 to 7) significantly reduced lordosis quotients of adult
female rats in both a paced and non-paced testing paradigm (34). Exposure to 400 ng/kg/day
of 17α-ethinyl estradiol in utero and during lactation induces sterility in exposed rat pairs
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(35) because it disrupts the estrous cycle with females showing permanent estrus as early as
at 60 days of age (36). Lower, environmentally-relevant dosages of 4 ng/kg/day produces
significant alterations in fecundity (35). In egg exposure to a variety of EDCs permanently
alters male copulatory behavior of the Japanese quail (37-39). These data clearly indicate
that developmental exposure to EDCs can adversely affect sexual development in animals,
supporting the hypothesis that similar effect may be occurring in people; however, there are
different effects depending upon the chemical nature of the EDC, the type of interaction
with hormone receptors, and when in development exposure occurs. Because there are many
factors that contribute to reproductive functioning, and many ways in which EDCs may alter
these factors, it is important to conduct systematic studies in animal models in order to
differentiate the specific effects of EDCs on reproductive parameters. Timing of exposure is
a crucial factor when considering potential behavioral and endocrine consequences in both
animals and people.
The role of EDCs for sexually-dimorphic, non-reproductive behaviors and
incidence of sex-linked developmental disorders
Many behaviors, and the neuroendocrine pathways that regulate them, are sexually
dimorphic. These sex dimorphisms reflect adaptive differences for behavioral strategies in
coping as a result of sexual selection. Disruptions in these behaviors may lead to reduced
social adaptation and impaired responsiveness to environmental demands (40). Exposure to
EDCs can alter or eliminate these sex differences and produce striking differences between
behavioral responses of males and females that were developmentally exposed to EDCs.
This potential for altering sexually-dimorphic behaviors may be relevant for concerns
regarding increased developmental, cognitive, and/or emotional disabilities reported over the
past 30 years (41).
EDCs’ Effects on Neurodevelopmental Processes
EDCs may have particularly significant effects on neurodevelopmental processes because
many accumulate in fatty tissues of exposed individuals, are readily transferred across the
placenta prenatally, and are expressed in breast milk. In the past, much of the human and
wildlife health-related research on pesticides and other EDCs has dealt with more or less
immediate toxicity at relatively high dosages, or has been concerned only with the primary
mode of action. Field and laboratory studies using different animal models indicate that
developmental exposure to low doses of these compounds can affect behaviour in a sex-
dimorphic fashion. The mechanisms by which pesticides and other compounds exert EDC-
like effects at environmentall-relevant dosages might be different from those involved in
their acute neurotoxic effects, and a direct interference with steroid/pituitary/thyroid
hormones cannot be excluded.
Notably, there are significant increases in the incidence of attention deficit hyperactivity
disorder (ADHD) and autism spectrum disorders (ASDs, 42). Development of psychological
disorders with sex-biased prevalence rates may be associated with the disruption of
developmental trajectory and/or maturation of the sexually-dimorphic brain (43). Autism
spectrum disorders (44), attention deficit disorder, and depression (45), are disorders with
sex-biased prevalence rates. Disruption of hormonally-controlled, sexual differentiation of
the brain, may increase vulnerability for these, or other, sexually-dimorphic functions.
Exposure to endocrine disrupters e.g., PCBs, BPA that disrupt hormone function during
critical periods of prenatal development may influence susceptibility to sex- and/or
hormonally-differentiated aspects of behavior (46-47). Males are more vulnerable to these
disorders, which have salient motor and arousal components. Thus, the increase in the
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incidence of these disorders may reflect effects of EDCs on male-typical levels of arousal
and/or stress responsiveness.
Environmental factors, such as EDCs, in early life can lead to long-term changes in social
and/or sensory function, which are features of some developmental disorders. Multiple types
of developmental disorders share many characteristics, including a developmental timeline
and dysregulation of both social behavior and somatosensory function. Sensory impairment
is higher in children with neurodevelopmental disorders than in the general population (48).
In individuals with ASD, sensory abnormalities are highly prevalent (30-100%; (49). In
addition to atypical sensory function, children with developmental disabilities often manifest
social problems, such as aggression (50). Thus, it is important to further understand factors
that increase susceptibility to psychological disorders (as indicated by differences in
expression of sex-typical behavior).
Organophosphorous insecticides (OPs) make up about 50% of all insecticides used in the
world, and are the subject of intensive investigation for their suspected developmental
neurotoxicity. These compounds, largely used in agriculture, home and garden for pest
control, exert their acute neurotoxic effects through cholinergic hyperstimulation. Since
2004, several epidemiological studies involving children from both agricultural and urban
communities have indicated that developmental OP exposure may affect children’s
neuropsychological maturation (for a review see (51)). Most of experimental research in this
field has focused on the OP chlorpyrifos (CPF) the most widely applied compound in the OP
class in US and Europe (52). The mechanisms by which CPF interferes with brain and
behavioral maturation at environmentally relevant dosages differ from those involved in its
acute toxic effects (53). Gestational and neonatal exposure to CPF impairs neuronal
differentiation, synaptogenesis and gene expression in rats, and affects neural systems
further than the cholinergic one, such as serotoninergic and dopaminergic transmission, in a
sex-dimorphic fashion (54-55).
The neurobehavioral effects of per os gestational and/or neonatal exposure to CPF have
been extensively characterized in mouse models. Overall, data show that CPF differentially
affects behavioral responses in the two sexes (56-59). In utero exposure to CPF modified
ultrasound emission in neonates and had pro-aggressive effects in adolescent and adult male
mice in a social interaction test. In adult females, prenatal CPF altered the pattern of social
interaction, either with same-sex partners or with a male-intruder during a test of the defence
of the nest. These behavioral changes are accompanied by permanent alteration in
expression of the hypothalamic neuropeptides, oxytocin and vasopressin, which are key
effectors of social and reproductive behavior in mammals. Furthermore, decreased
behavioural responsiveness to antidepressant drugs acting on serotonin transporter in CPF-
exposed males, confirms that serotonergic neurotransmission is implicated in the
behavioural effects of CPF (60,61).
In a study still in progress (Calamandrei et al., unpublished), pregnant females have been fed
throughout gestation and lactation with a CPF-supplemented diet, to mimic the human
exposure scenario. At adulthood, CPF-exposed males display enhanced investigative
response towards either familiar or unfamiliar same-sex individuals, whereas CPF females
show delayed onset of social investigation and lack of reaction to social novelty. In addition,
sexually-dimorphic effects have been revealed so far in the hypothalamus: CPF females
show diminished expression of the oxytocin precursor neurophysin I, increase of estrogen
receptor (ER) α and decrease of ERβ. ERα and ERβ in the hypothalamus/amygdala circuitry
are known to exert a facilitatory role in oxytocinergic control of social recognition in rodents
(62). These preliminary data suggest that developmental CPF interferes with maturation of
important sexually-dimorphic neuroendocrine pathways.
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Together, these experimental findings support the hypothesis that in utero or neonatal
exposure to extremely low dosages of CPF influences neurobehavioral development, affects
multiple signalling systems, including those controlling reproduction, with effects on
behavior that are long-term and differ in the two sexes. The case of CPF might be
prototypic: it is likely that other environmental neurotoxicants, not yet considered as EDCs,
might indeed interfere with neuroendocrine functions, possibly concurring to increase
vulnerability to sex–biased neurodevelopmental disorders in children.
Cognitive Function
There may be sex-specific effects of estrogenic EDCs on spatial learning, which typically
favors males. Yu-Cheng boys that were prenatally exposed to high levels of PCBs and
PCDFs, when their mothers were accidentally exposed to these contaminants in rice oil,
show more disrupted cognitive development, mainly spatial function, than did exposed girls
(63). Gestational and lactational exposure to ortho-substituted PCBs produces spatial deficits
at adolescence in male mice (64). Prenatal exposure to PCBs 28 or 153 had dose-dependent
effects to slow acquisition of the radial arm maze task for female, but not male, rats (65).
Notably, gestational exposure to Aroclor 1254 (vs vehicle) produced more working memory
errors in the radial arm maze task for male rats, but not female rats (66). Another study
showed that of rats exposed in utero and postnatally through weaning to Aroclor 1254,
males were more likely to perseverate following reversal in the radial arm maze task,
whereas females were more likely to have association deficits (67). A small body of
literature has shown that EDCs may facilitate cognitive functions in some cases. For
example, exposure of male rats to 17α-ethinyl estradiol during development (from gestation
day 5 to weaning) results in enhanced working memory during a Morris water maze hidden
platform acquisition test (68). These observations again highlight the potential for non-linear
responses and the complexity of interpreting the ethological-relevance of behavioral
outcomes. Collectively, the literature supports the conclusion that exposure to EDCs from
early development to adulthood alters spatial memory and there may be sex differences in
these effects.
Emotional Reactivity and Stress Responses
Gestational or early life exposure to EDCs may influence arousal. It has long been known
that exposure to heavy metals, such as lead or mercury, can lead to behavioral disorders in
people (69). Epidemiology studies of populations exposed to high levels of PCBs reveal that
EDCs may produce similar outcomes (70). Children exposed to PCBs, lead, or mercury
show inattention, hyperactivity, disordered and/or mildly antisocial behavior (41, 45). There
is also evidence for increased aggression (69, 72). Prenatal BPA exposure has now been
linked with increased externalizing behaviors in 2-year old girls (73). Atypical behaviors in
infancy and childhood, including compromised social communication, have also been
associated with prenatal exposure to phthalates (74) compounds found in soft plastics that
act as androgen antagonists.
In animal models, developmental exposure to EDCs produces similar effects. Exposure to
PBDE 209 on post-natal day 3 disrupts spontaneous motor behavior in rats (75). Another
study that administered BPA to five-day old rats observed hyperactivity at 4-5 weeks of age,
which was associated with changes in dopamine function in midbrain (76). Mice exposed
perinatally (from gestation day 11 to postpartum day 8) to BPA or methoxychlor, showed a
reversal of sex differences at periadolescence in exploratory activity in a novel open field,
elevated plus maze, and social interactions with a conspecific (77,78). Similarly, anxiety,
spatial learning and memory, and passive avoidance memory were found to be altered in
mice exposed to BPA (40 or 400 g/kg/day) across adolescence and early adulthood, with sex
differences eliminated or reversed on many tasks (79). Similar effects of BPA have also
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been reported in deer mice (Peromyscus maniculatus) (80) and rats (81). To our knowledge,
there are few published reports of effects of EDCs on stress reactivity. A recent study
revealed that early life stressors, such as cross-fostering, can modulate the effects of BPA on
social behavior and anxiety (82). This highlights the need for further investigation of the
impact of EDCs on hypothalamic-pituitary-adrenal axis function, albeit there is emerging
evidence that EDC can alter oxidative stress (83).
EDCs Influence Brain Morphology
Several studies have investigated EDCs effects on sexually dimorphic brain circuits. For
example, rats exposed to Aroclor 1221 perinatally had fewer ERβ positive cells in the
sexually dimorphic nucleus of the preoptic area (SDN-POA) than did vehicle-administered
rats (84). Exposure to BPA during the pre- or postnatal period can alter the differentiation of
several neural circuits involved in the control of reproductive functions and behavior. It
induces an increase of ERα mRNA and protein expression in the female rat hypothalamus
and in the male anterior pituitary (85,86), and alters the sex specific expression of tyrosine
hydroxylase (TH) in the rat and mouse anteroventral periventricular nucleus (87-88). Also
other systems, such as the rat locus coeruleus (89, 90), the mouse nitric oxide producing
system (91), and the rat and mouse kisspeptin system (92, 93), are affected by precocious
exposure to BPA, altering in many cases, their sexually-dimorphic expression.
The family of neurohypophyseal nonapeptides (arginine-vasopressin (AVP) in mammals
and arginine-vasotocin (AVT) in non-mammalian vertebrates) is present in magnocellular
system and in the sexually-dimorphic parvocellular systems of hypothalamus and limbic
system. This last system is gonadal hormone-dependent in various vertebrates [for a review
of comparative aspects see (94, 95)]. It is involved in the control of male copulatory
behavior in birds (96, 97) and in the modulation of aggressive behavior and other social
behaviors in mammals and other vertebrates (98). Administration of exogenous estrogens
demasculinizes this system in birds (99), whereas in mammals, both estrogens and
androgens may contribute to the masculinization of the system (100-103). In adulthood,
gonadal hormones modulate the expression of AVP or AVT, both in the parvocellular
(104-106), and in the magnocellular system (107). Thus, the AVP system has been
considered as a potential target for the action of EDCs (108, 109).
In the Japanese quail, embryonic exposure to different EDCs (DES, genistein, or DDE)
induced a significant demasculinization of the sexually dimorphic parvocellular AVT
system (37-39). For other EDCs [ethynylestradiol (EE2) and methoxychlor (MCX)], the
effects on this neural system were absent or not significant, yet they did affect copulatory
behavior (110). The dissociation between demasculinization of behavior and the AVT
system suggests that estrogens induce these effects via at least partly different pathways. As
demonstrated through the administration of an ERα selective agonist, propyl pyrazole triol
(PPT), estrogen-induced effects on reproductive organ differentiation are mediated by ERα,
whereas demasculinization of male copulatory behavior and of the AVT-immunoreactive
(ir) system are probably dependent upon ERβ, which appears earlier during quail embryonic
development than does ERα (111).
In mammals, acute exposure to E2 stimulates the synthesis of the mRNA AVP (112) and
induces a significant increase of AVP immunoreactivity in magnocellular nuclei of female
rat (107). In rats, dietary exposure to phytoestrogen genistein (from prenatal day 7 up to the
age of 2 months and a half) induced an increase of vasopressin content in hypothalamic
extract (113). However, exposure to organoalogen compounds, generally believed to act as
antiandrogens, inhibited the release of AVP from SON punches and in vivo (114,115).
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These studies suggest that also in mammals the AVP system is a target for the action of
EDCs (108).
A few studies have investigated the second neuroypophyseal nonapeptide, oxytocin (OT),
produced by the magnocellular nuclei in mammals, and released both centrally into the
brain, and peripherally into the circulation. OT is involved in social recognition and
maternal behavior (116, 117). Oral BPA exposure reduces certain maternal behaviors in
female rat, such as licking-grooming and arched back posture, that are related to OT (35). At
the same time, BPA may induce an increase in OT-immunoreactive cell number in female
rat PVN (118) suggesting that it may inhibit OT release. The behavioral effects of EDCs
exposure could also be related to alteration of the expression estrogen-inducible central OT
receptors (119), as observed in the cingulate cortex of female pine vole perinatally exposed
to MXC (120). Together, these data demonstrate that EDCs can negatively affect sexual
dimorphisms in the brain (for recent reviews see (3, 4, 121).
Other EDCs, as the 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), may have large effects in
the brain when prenatally administered. In particular, prenatal exposure to TCDD (700 ng/
Kg single dose gavage at gestational day 18) affects the offspring in the number of pups
born, myelination, weight gain and sex ratio towards females (122-126). Major alterations
observed in offspring of TCDD exposed dams were a higher expression of oligodendrocyte
precursor cell (OPC) markers mRNA, Olig-1 and PDGFaR, in diencephalon and cerebellum
and altered content of myelin basic protein being lower in mature cerebellum, diencephalon
and medulla oblongata and conversely, higher in the telencephalon (127). Collectively, these
results point to a long-lasting gliogenesis defect in mature brain after prenatal TCDD
exposure (122).
Different molecular mechanisms could be responsible for the described defects. One effect
may be related to a direct TCDD effect on OPC via aromatic hydrocarbon receptor (AhR),
during the critical period of OPC proliferation, migration, and maturation (123). As
oligodendrocyte generation, maturation and myelin protein expression are under thyroid
hormone control, another possibility could be related to indirect effects of TCDD on
endocrine function, e.g. thyroid dysfunction. Indeed, perinatal TCDD exposure alters
maternal, neonatal, and infant thyroid function, as well as thyroid hormone nuclear receptor
(TR)-mediated gene expression and pathways (128). The cerebellar expression of TRα
mRNA was down regulated during development, whereas TRβ mRNA significantly
increased, within the second postnatal week, then turning to basal expression levels at
adulthood. The expression of deiodinase enzyme D2 mRNA was very low in the first
postnatal days, significantly increased during development and reached a peak after 14 days.
On the contrary, D3 mRNA was highly expressed at 2 days postnatal but its expression was
drastically down regulated during development. These results are in line with what has been
already described (129). Interestingly, there are significant difference in the expression of
TRα-1 at 14 days postnatal in TCDD-, versus vehicle-exposed, males, but not, female rats.
Thus, we can conclude that prenatal exposure to TCDD alters developmental expression
profile of several genes, including myelination and thyroid hormone related genes, thereby
affecting expression profile of one of the main signalling pathways for brain development.
Consideration of critical periods
When, in life, exposure occurs may be critical for EDCs’ effects. Critical periods of
urogenital tract and nervous system development in utero or in early post-natal life are
especially sensitive to hormonal disruption. Damage during these “critical windows of
development” may be more likely to be permanent, yet, in mature individuals, ill effects of
exposures can be alleviated when the causative agent is removed (130). This is consistent
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with the idea of greater negative consequences with BPA exposure during infancy/childhood
vs. adulthood (14). In rats, the effects of EDCs at environmentally-relevant dosages appears
to be particularly strong when the exposure is protracted for the entire developmental period,
i.e. from gestation to weaning (35-36). Persistent effects have also been observed when
exposure is confined to a specific critical window, such as the neonatal period (131-132). In
any case, exposure to EDCs is likely to be continuous in natural populations because they
are ubiquitous in the natural and human environment (133).
Exposure to EDCs during other critical periods- perinatal, juvenile, puberty
In rats, exposure to environmentally-relevant concentrations of 17α-ethinyl estradiol (4 ng/
kg/day) from gestation day 5 to weaning (postnatal day 32) has serious effects on sexual
behavior, cognitive functions, and reproduction (35, 36, 68). In females, sexually proceptive
behavior is affected, with a disruption of the timing of appearance of appetitive aspects
during the copulatory sequence (36). Reproduction is also affected, with an increase in the
number of live pups (35). Similarly, there is an improvement in spatial learning in male rats
tested in a Morris water maze (68). Inverted U-shaped dose-response curves are quite
common for EDCs (‘hormesis’: see (134), but even if these effects are positive, they are
unlikely to be beneficial (135).
In mice, exposure of pregnant dams to low doses of BPA, from prenatal day 10 to postnatal
day 8 (5, 10, 20, 40 μg/kg/day), induced profound behavioral alterations in adulthood. In our
preliminary study (136), males showed an increase in the time spent in the intermediate and
central areas of the open field, suggesting that perinatal exposure to BPA may determine
anti-anxiety effects. At the same time, we observed a significant increase of the spontaneous
activity of mice within the T-maze, suggesting cognitive deficits in animals. BPA-treated
mice of both sexes had a strong reduction in the time spent in the arm with opposite-sex
bedding; in males, we also observed the reduction of number of sniffing in the same arm.
These findings suggest that BPA may alter the olfactory system and, as a consequence,
sexual behavior. This is in agreement with the results of our recent study demonstrating
alterations in part of nNOS system in mice perinatally exposed to BPA (91). On the
contrary, we have neither detected changes in food preference nor searching. Finally, we
observed alterations of sexual behavior only in males. In particular, we observed deficits of
ano-genital and body sniffing, and allo-grooming behaviors. In females, we observed a
significant advancement of puberty. In a second experiment, we exposed perinatally-treated
mice to a second exposure to BPA from day 31 to day 60. The behavioral alterations were
essentially the same. This suggests that some of the effects of BPA on behavior may be
predominantly organizational rather than activational.
Genistein, as other phytoestrogens, is largely present in human and laboratory animal diets.
Phytoestrogens have recently gained recognition for their beneficial effects on human
health, but little is known about their effects on brain circuitries. Experiments carried out on
rats fed with phytoestrogen-rich diet have shown contrasting results on behavior and related
brain areas. To understand if exposure to genistein during the postnatal critical period of
differentiation of brain circuits and behaviors may alter this process, we orally administered
male and female mice from postnatal day 1 to post natal day 8, genistein (50 mg/kg in
sesame oil), or vehicle. Mice were tested at postnatal day 60 for anxiety behavior, using the
Elevated Plus Maze and the Open Field. The results indicated a strong sexual difference. In
fact, genistein demonstrated an anxiogenic effect in males and an anxiolytic effect in
females (137).
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Puberty
Maturation and function of the vertebrate reproductive system is coordinated by the
hypothalamic-pituitary-gonadal (HPG) axis. This sexually dimorphic system encompasses a
complex network of hypothalamic neuronal signaling pathways, the most notable of which
is the newly discovered kisspeptin system (for a recent review see (138) and this issue), that
enable the sex-appropriate regulation of gonadotropin secretion by steroid hormones. The
neural components of the HPG axis, including kisspeptin pathways, are sexually-
differentiated by endogenous gonadal hormones (primarily estradiol in rodents but perhaps
both estrogens and androgens in humans) through a series of gestational, pre- and perinatal
critical periods (139-142). This sex-specific ontogeny can be manipulated by the exogenous
administration of steroid hormones during the neonatal critical period. For example,
neonatal estrogen administration masculinizes the female rodent brain, resulting in the loss
of the preovulatory GnRH surge, while castration effectively prevents defeminization of the
male rodent brain (143).
In females, exposure to EDCs during the neonatal period can also perturb the sex-specific
organization of these hypothalamic pathways resulting in advanced vaginal opening, a
hallmark of rodent puberty, and abnormal estrous cyclicity (81,-144-148. For example, in
female rats, exposure to 10 mg/kg genistein, an isoflavone phytoestrogen common to soy-
based foods, across only the first few days of life, results in significantly decreased
kisspeptin fiber density in the region surrounding GnRH neurons during peripubertal
development (147). This male-like pattern of kisspeptin fiber density persists into adulthood
(93, 144) and is accompanied by an impaired capacity to stimulate GnRH neuronal activity
(as measured by the immunoreactivity of both of GnRH and Fos) following ovariectomy and
hormone priming (144). These results indicate that disrupted organization of the kisspeptin
signaling pathways may be a novel yet fundamental mechanism by which a suite of
reproductive abnormalities are induced including disrupted timing of pubertal onset,
irregular estrous cycles and premature anovulation.
Exposure to EDCs in Adulthood Also Affects Reproductive Parameters
To date, there has been much less investigation of the activational effects of EDCs compared
to their organizational effects. There is some evidence of EDCs altering reproductive
responses of adults. Men with infertility had significantly higher tetra- and pentachlorinated
biphenyls, DDE, DDT, and lindane than controls (149). Lead exposure increases male and
female infertility (150, 151). Administration of Aroclor 1221 or 1254 during adulthood
affected the timing of female sexual behavior of rats (152) and women consuming a high
soy diet experience disrupted menstrual cycles and difficulty obtaining pregnancy (153).
Thus, the extent to which exposure during adulthood may influence previously established
sexually dimorphic behaviors is of continued interest.
Potential Mechanisms by Which EDCs May Produce Their Effects
The putative mechanism by which EDCs may have their effects needs to be more
thoroughly explored. An important question is whether EDCs interact with endogenous E2.
This is relevant not only for women of reproductive age, who have high and fluctuating E2
levels, but also for children, postmenopausal women, and men, whose E2 levels are low.
Although PCBs have long been known to be estrogenic (154), EDCs vary in their estrogenic
effects. Attempts to establish a relationship between PCBs and their estrogenic/
antiestrogenic actions have not reached a consensus (155. A review follows of potential
species differences and actions of EDCs.
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Effects of endocrine disrupting chemicals mediated by aryl hydrocarbon receptors and
CYP1A1
Many effects of EDCs are mediated by the aryl hydrocarbon receptor (AhR), which is
present in various tissues including brain (156). This receptor may be responsible for dioxin
and dioxin-like PCB intoxications, which create severe clinical problems, such as behavioral
and cognitive impairments and an increased number of newborns with improperly formed
brains (157). However, it has become evident that AhR may also be involved in neural
development, likely through interaction with Wnt signaling (158), in addition to mediating
neuronal cell death in response to environmental pollutants.
The molecular mechanism underlying AhR-induced neurotoxicity is largely unknown and
related mainly to necrosis. Prenatal exposure to AhR agonist TCDD (tetrachlorodibenzo-p-
dioxin) resulted in neurodevelopmental deficits, possibly due to altered activity of Sp1 factor
and increased oxidative stress (159). Exposure to TCDD, 8 weeks prior to pregnancy,
resulted in 50-75% decrease in serotonergic neurons in the mouse raphe nuclei (160).
Furthermore, treating animals or neocortical cell cultures with TCDD altered expression of
NMDA receptor subunits, could directly influence necrosis of neuronal cells (161, 162).
Little is known; however, about apoptotic effects mediated by AhR. This is particularly
important because apoptosis occurs at each stage of neural development and may also be
attributed to neurodegenerative diseases.
There are few data, including ours, suggesting that AhR regulates brain apoptosis (163-165).
AhR is a ligand-dependent transcription factor that activates transcription of genes, such as:
CYP1A1, CYP1A2, and CYP1B1, and oncogenes (166). CYP1A1 is the most commonly
and consistently expressed isoform, which is involved in biotransformation, metabolism and
detoxification of many environmental contaminants, including polycyclic aromatic
hydrocarbons (PAHs). This cytochrome is also involved in the metabolism of endogenous
substrates like estradiol (167). EDCs may alter the CYP450 system through binding to the
AhR acting as either agonists or antagonists (168). In the absence of ligand, AhR is bound to
heat shock protein Hsp90. Upon ligand binding, the AhR translocates into the nucleus
whereupon it heterodimerizes with the ARNT protein (hydrocarbon receptor nuclear
translocator) and binds to AhR DNA recognition site, known as XRE (xenobiotic response
element). The location of XRE close to the ERE (estrogen response element) allows AhR-
and estrogen receptor (ER)-mediated transcription processes to be reciprocally affected. At
present, both ER subtypes are known to contribute to neuroprotection, but the relative
contributions of ERα and ERβ remain unresolved. It is noteworthy that AhR-dependent
activation of proteasomes mediates degradation of ERα (169. We showed for the first time,
co-localization of AhR with ERβ in neocortical tissue, thus suggesting an interactive action
between these receptors (165)). One possible interaction is through ARNT, a dimerization
partner of AhR that can act as a potent co-activator of ERβ (170). This supported our
biochemical data that, among estrogen receptors, ERβ is the most crucial for compromising
AhR-mediated neuronal cell death.
Effects of EDCs on E2 Metabolism
EDCs may have effects on E2 metabolism in a number of ways. Some EDCs can alter serum
lipid concentrations, ultimately enhancing production of E2 and other steroids. Further, some
EDCs can alter metabolism enzymes that are necessary for converting cholesterol to steroid
hormones. Numerous EDCs can activate one of the P450 cytochromes (P450 or CYP),
which are involved in the metabolism of most steroid hormones and EDCs. Environmental
contaminants may contain chemicals that induce P450s, are metabolized by P450s, or both.
Induction of CYP occurs when EDCs, such as TCDD, bind AhR. There is a firm link
between PCBs, enzyme induction, and AhR effects (171; 172). Coplanar PCBs like TCDD,
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activate AhR, cause the induction of CYP, which catalyzes the metabolism of many PCB
congeners and other endogenous hormones, including E2 (169, 173). The binding of EDCs
with AhR can result in antiestrogenic activity through increased metabolism and depletion
of endogenous E2 (173). Elevated levels of CYP enzymes, primarily expressed in the liver,
but also in brain and other tissues, result in increased E2 metabolism and excretion.
Alternatively, compounds that are metabolized by P450s may produce estrogenic effect if
they inhibit endogenous estrogens from being metabolized.
Estrogens can produce anti-androgenic effects by inhibition of testicular androgen secretion
via blocking secretion of lutenizing hormone or by direct suppression of T synthesis by
Leydig cells. High levels of PCB-inducible androstenedione formation have also been found
(174). PCB exposure reduced testicular microsomal P450s and affected androstenedione
formation and 16α-hydroxylation of T. Mitochondrial CYP, the rate-limiting enzyme of
steroidogenesis, was inhibited by 50% in testes of animals exposed to EDCs (175). Adult
male rats given single doses of TCDD exhibited decreases in plasma T and
dihydrotestosterone concentrations by 90 and 75%, respectively, and decreased seminal
vesicle and ventral prostate weights (176). PCB 126 can suppress 5α-reduction of T, or
progesterone, in liver microsomes (177). A question for further consideration is the
importance of EDCs’ effects on steroid metabolism to mediate behavioral processes.
Species differences and food-chain effects, metabolism
Among vertebrates, teleost fishes exhibit unique features in terms of neurodevelopment and
brain sexualization. In contrast to a common thinking, teleosts are not primitive vertebrates,
but vertebrates that belong to a lineage that diverged from the tetrapod lineage some 450
million years ago. Among teleosts, there are primitive and highly evolved species. However,
all share the property of growing their brains during their entire lifespan, a feature that is
supported by the fact that adult fish conserve active radial glia progenitors throughout life.
These cells are notably capable of performing asymmetrical divisions that give birth to new
neurons not only during embryonic development, but also in adults (178,179). In addition,
the radial glial cells of fish are now well documented for expressing steroidogenic enzymes,
notably aromatase B, the product of the cyp19a1b gene (178-181). This gene is in fact
strongly up-regulated by estrogens and any xenoestrogens capable of activating one of the
three zebrafish estrogen receptors (178, 181-184). In zebrafish embryos and larvae, exposure
to estrogen and estrogen mimics causes a strong increase of cyp19a1b expression that, in
contrast, remains low in controls at early developmental stages (185). This means (i.) that
radial glia progenitors are direct targets of xenoestrogens and (ii.) that this gene is an
excellent biomarker of xenoestrogen exposure that can be used in vitro (182) and in vivo
(178, 181) to address current key questions, such as the effects of mixtures and/or the
monitoring of environmental samples.
A very high aromatase activity is another feature that makes the brain of adult fish so special
and, in a way, similar to that of embryonic mammals (178, 186). In mammals, at least in
rodents, it is believed that aromatase activity is strongly implicated in brain sexualization
(187). It is believed that these effects are mediated in part through a region-specific
modulation of apoptosis (188, 189). However, aromatase and estrogens are also important in
the regulation of neural development, synaptic plasticity and cell survival outside the
classical “reproductive brain”. Aromatase knocked-out mice have documented the potential
effects in the development of some brain regions, such as the cortex. A wealth of evidence
now supports the view that locally-produced estrogens acting in paracrine or autocrine ways
modulate neuronal survival and brain functions. Therefore, it is possible that the high
aromatase activity of the permanently developing brain of adult fishes also supports their
constant neurogenic activity. In this regard, the fact that aromatase in only expressed in
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radial glial cells provides an anatomical substrate for such a link between aromatase
expression and neurogenesis. These observations may also explain why many species of fish
are sequential hermaphrodites and can change sex as adults, a skill that requires great brain
plasticity (190). Our current studies now demonstrate that estrogen-like compounds not only
modulate aromatase expression and activity in the radial glial cells, but also their
proliferation (N. Diotel et al., unpublished data). Thus, altogether these data suggest that
xenoestrogens have the potential to disturb adult neurogenesis and sex change in adult fish,
which would mean that the critical window through which animals are highly susceptible to
endocrine disruptors would extend throughout the entire lifespan of fishes.
Obesogenic effects of EDCs
There is growing recognition that some EDCs can act as “obesogens” and increase the risk
of developing metabolic disorders such as diabetes (191-194). One notable obesogen is
DES, a synthetic estrogen initially prescribed to pregnant women to prevent miscarriage but
ultimately distributed more widely before its use was discontinued in the late 1970’s because
prenatal exposure was linked to a higher risk of vaginal (195). Children exposed in utero are
unfortunately at higher risk for a wide range of neuroendocrine disorders including
reproductive malformations, infertility and testicular cancer (196, 197). Emerging evidence
now suggests that this population may also be at greater risk for obesity and metabolic
disorders (193).
Organotin compounds, such as tributyltin (TBT), are also well recognized obesogens. These
compounds are used in agriculture and industry as biocide, heat stabilizer and chemical
catalyst (198). They may contaminate water and human foodstuffs, especially shellfish
(199-201). Due to their endocrine-disruptive effects, organotin compounds are toxic to
marine species, determining the development of ambiguous genitalia (200) and the increase
of androgens’ levels and the decrease of estrogens in clams’ tissues (201). Organotin
compounds are PPARγ and RXR agonists and they stimulate the differentiation of
preadipocyte 3T3-L1 cells into adipocytes (201), and modulate, in vivo, the expression of
PPARγ/RXR target genes in adipose tissue and liver, thus acting as potential obesogens
(202). In particular, TBT increases body weight in mammals (203) and disturbs levels of key
hormones linked to energy homeostasis (204). These data suggest a peripheral role of TBT
on obesity development, but, currently, there are only a few studies on the effects of TBT on
the central nervous system. In a recent study (205), we demonstrated, for the first time in an
“in vivo model”, that oral administration of TBT in adult mice may specifically activate
(specific increase of c-fos expression) a key region of the circuits involved in the control of
food intake, the ARC nucleus. This nucleus is the source of the NPY- and of MSH-circuits
that are regulating the stimulation or the depression of the food intake stimulus. Our
preliminary results indicate that NPY expression is indeed affected by adult exposure to
TBT (206), as well as to other EDCs (i.e., BPA and DES (207)).
Other Substrates to Consider for Actions of EDCs
One challenge to understanding effects and mechanisms of EDCs regards their many and
variable responses and/or actions of E2-sensitive targets. For example, EDCs can mediate
responses of two orphan receptors of the nuclear receptor family, the constitutive androstane
and pregnane X receptors (208). As well, EDCS may have actions at membrane-associated
ERs (“non-genomic” actions) (209-211). Like E2, EDCs may have steroid receptor-
independent actions through numerous other substrates, such as signal transduction
pathways, calcium influx, and/or neurotransmitter receptors. Of particular interest is the role
that EDCs have via neuropeptide systems (121). Investigations of the extent to which EDCs’
actions involve metabolism and or ER and non-ER mechanisms for behavioral responses are
ongoing.
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Summary/Conclusions
Individuals may be exposed to EDCs from varied sources, including pesticides and
herbicides, dust, plastics, medical and/or dietary components (Fig. 1). EDCs can influence
reproductively-relevant or non-reproductive, sexually-dimorphic behaviors. Exposure to
EDCs during critical phases of development (e.g. perinatal, peripubertal periods), may result
in more salient effects on neurodevelopmental and/or reproductive processes. However,
exposure to EDCs in adulthood can alter physiological processes including production of
steroids, actions via, or independent of, classic cognate steroid receptors. EDCs may have
effects through other substrates, such as the AhR, PPAR, and retinoid, androstane, or
pregnane X receptors, neurotransmitters, calcium or signal transduction. EDCs, from varied
sources, may organize and/or activate sexually-dimorphic, neurodevelopmental and/or
reproductive processes or other functions, by mimicking, antagonizing, or altering steroidal
actions.
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Figure 1.
A schematic representation of varied sources of endocrine disrupting chemicals (EDCs) and
how they may influence sexually-dimorphic, reproductive and neurodevelopmental
processes, in particular through their actions during critical periods of development. Some of
the steroids mechanisms that may mediate actions of EDCs are included.
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